Stock screener
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
290 stocks
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | Score | P/E | Margin of safety | Rev. growth | Net margin | Yield | 1Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | $504.80 | −10.9% | $824B | 15 | 130× | −229% | +39.5% | 15.6% | – | +91.0% | |
| 2 | $406.97 | −0.96% | $365B | 11 | 26.2× | – | +6.5% | 3.1% | 2.2% | +14.6% | |
| 3 | $250.43 | −4.1% | $256B | 12 | 4007× | – | +24.3% | 1.1% | – | +83.6% | |
| 4 | $306.08 | −7.3% | $108B | 9 | – | – | +32.0% | −20.1% | – | +13.5% | |
| 5 | $840.70 | −8.6% | $75.4B | 8 | – | −506% | +83.2% | −230% | – | +292% | |
| 6 | $52.15 | +1.9% | $57.4B | 8 | 12.4× | −26.3% | +14.6% | 16.7% | 2.1% | +62.7% | |
| 7 | $258.70 | −10.9% | $44.9B | 12 | 128× | −342% | +98.5% | 30.7% | – | +49.0% | |
| 8 | $274.37 | −7.4% | $42.9B | 20 | 31.5× | +7.3% | +74.9% | 27.5% | 0.19% | +57.7% | |
| 9 | $32.12 | +0.38% | $42.2B | 5 | – | −21.0% | +11.5% | 4.1% | – | – | |
| 10 | $191.31 | +0.55% | $41.0B | 3 | – | – | – | – | – | +230% | |
| 11 | $83.63 | −0.82% | $34.3B | 7 | 26.5× | −18.2% | +3.4% | 11.9% | 1.3% | +22.0% | |
| 12 | $54.73 | −7.4% | $32.7B | 8 | – | −187% | +52.5% | −21.5% | – | −17.3% | |
| 13 | $54.87 | −9.7% | $30.3B | 1 | – | −142% | +115% | −25.4% | 0.00% | −60.8% | |
| 14 | $36.91 | −1.6% | $26.7B | 7 | – | – | −67.6% | −3535% | – | +96.7% | |
| 15 | $124.15 | −7.1% | $25.7B | 10 | – | – | +42.4% | −16.5% | – | +72.6% | |
| 16 | $73.47 | −1.8% | $24.8B | 7 | 13.3× | −375% | +32.2% | 45.3% | – | +1.1% | |
| 17 | $91.73 | −29.2% | $17.6B | 15 | 21.3× | +9.8% | +66.6% | 31.3% | – | −56.5% | |
| 18 | $343.12 | −1.6% | $16.4B | 2 | – | −189% | +60.8% | – | – | −13.9% | |
| 19 | $94.39 | −4.5% | $11.6B | 11 | – | −198% | +26.4% | −7.3% | 0.00% | +95.5% | |
| 20 | $21.65 | −3.0% | $11.5B | 8 | – | −218% | +43.4% | −123% | – | −57.4% | |
| 21 | $11.04 | −3.0% | $11.5B | 6 | – | +14.7% | +408% | −5.2% | – | −40.3% | |
| 22 | $57.50 | +1.2% | $11.2B | 2 | – | −49.4% | – | 2.3% | – | +7.7% | |
| 23 | $83.53 | −0.64% | $10.8B | 5 | – | −304% | +7.7% | −19.4% | – | +99.9% | |
| 24 | $77.02 | −1.2% | $10.6B | 6 | – | −26.7% | +1.3% | −0.64% | – | +96.6% | |
| 25 | $24.30 | −7.2% | $9.9B | 8 | – | −591% | +30.4% | −91.8% | – | +3.8% | |
| 26 | $332.29 | +2.4% | $9.8B | 10 | 41.6× | −111% | +22.6% | 54.8% | – | +79.6% | |
| 27 | $110.19 | −1.1% | $9.6B | 15 | 19.2× | +11.7% | +7.4% | 38.6% | 4.1% | +15.4% | |
| 28 | $56.15 | −4.8% | $9.4B | 16 | 54.5× | −24.1% | +17.1% | 16.1% | 0.61% | +18.4% | |
| 29 | $30.37 | −1.4% | $9.4B | 11 | 21.7× | −28.3% | +42.8% | 3.6% | – | +60.6% | |
| 30 | $61.18 | +5.3% | $9.4B | 10 | 22.3× | +19.7% | +76.1% | 55.2% | – | +81.1% | |
| 31 | $35.92 | +0.17% | $8.6B | 11 | 20.5× | −71.3% | +13.8% | 38.3% | 1.0% | +76.5% | |
| 32 | syreSpyre Therapeutics | $96.56 | −2.4% | $8.5B | 7 | – | – | – | – | – | +305% |
| 33 | $53.76 | −0.83% | $8.3B | 13 | 8.9× | +19.9% | +20.8% | 13.5% | 1.8% | +56.3% | |
| 34 | $28.52 | 0.00% | $8.3B | – | – | – | – | – | 1.2% | +1179% | |
| 35 | $76.29 | −1.9% | $8.3B | 17 | 8.6× | +17.7% | +141% | 486% | 2.2% | +0.22% | |
| 36 | $41.00 | −1.3% | $7.9B | 14 | 20.1× | +9.3% | +6.5% | 40.4% | 5.9% | −0.27% | |
| 37 | $25.81 | −9.0% | $7.9B | 6 | – | −71.0% | +88.5% | 5.8% | – | – | |
| 38 | $23.38 | −1.7% | $7.7B | 10 | 24.1× | +29.4% | +12.6% | 5.1% | – | −18.3% | |
| 39 | $110.90 | −3.4% | $7.7B | 12 | 30.1× | −14.7% | +5.5% | 5.4% | 1.3% | +39.9% | |
| 40 | $47.81 | −3.8% | $7.6B | 12 | 27.3× | −20.1% | +15.2% | 4.8% | – | +284% | |
| 41 | $65.55 | +1.0% | $7.4B | 5 | – | −415% | +14.6% | −0.28% | – | – | |
| 42 | $59.40 | −10.6% | $7.3B | 1 | – | −457% | – | −189% | – | +14.4% | |
| 43 | $18.34 | −1.1% | $7.2B | 20 | 6.8× | +61.8% | +4.3% | 6.8% | 6.5% | −15.9% | |
| 44 | $24.34 | +0.12% | $6.9B | 5 | – | −107% | +1.3% | −16.8% | 2.8% | +44.0% | |
| 45 | $165.13 | −3.8% | $6.8B | 10 | 105× | −130% | +15.5% | 5.6% | – | +17.8% | |
| 46 | $26.10 | −2.0% | $6.8B | 5 | – | −101% | +34.8% | −42.1% | – | – | |
| 47 | $322.75 | +1.7% | $6.4B | 6 | 141× | −498% | +1.0% | 20.3% | – | +74.9% | |
| 48 | $96.87 | +0.23% | $6.4B | 7 | – | – | – | – | 0.00% | +251% | |
| 49 | $51.31 | +3.3% | $6.3B | 18 | 9.1× | +34.4% | +4.9% | 18.6% | 3.4% | +1.0% | |
| 50 | $16.00 | −11.7% | $6.3B | 3 | – | – | +24.7% | −0.49% | – | −56.1% |